Determination of sensitivity and specificity of a novel gene dosage assay for prenatal screening of trisomy 21 syndrome (original) (raw)

Non-Invasive Prenatal Detection of Trisomy 21 Using Tandem Single Nucleotide Polymorphisms

Sujana Ghanta

PLOS One, 2010

View PDFchevron_right

Rapid non-invasive prenatal screening test for trisomy 21 based on digital droplet PCR

Marie Korabecna

Scientific Reports, 2023

View PDFchevron_right

Could Digital PCR Be an Alternative as a Non-Invasive Prenatal Test for Trisomy 21: A Proof of Concept Study

Laurent Mandelbrot

PloS one, 2016

View PDFchevron_right

Influence of first trimester biochemistry methodology on detection rate in screening for trisomy 21

Dariusz Borowski

Ginekologia Polska, 2017

View PDFchevron_right

First Trimester Biochemical Screening for Trisomy 21

Tim Reynolds

Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, 1995

View PDFchevron_right

Screening for trisomies 21, 18 and 13 by cell‐free DNA analysis of maternal blood at 10–11 weeks' gestation and the combined test at 11–13 weeks

Gergő Orosz

Ultrasound in Obstetrics & Gynecology, 2014

View PDFchevron_right

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study

Tak Leung

BMJ, 2011

View PDFchevron_right

Prenatal detection of trisomy 21 and 18 from amniotic fluid by quantitative fluorescent polymerase chain reaction

Tamás Tóth

Journal of Medical Genetics, 1998

View PDFchevron_right

A Novel Multiplex Real-Time PCR Assay Using TaqMan MGB Probes for Rapid Detection of Trisomy 21

AHMAD KAMYAB

View PDFchevron_right

Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting

Roger Tim

American Journal of Obstetrics and Gynecology, 2011

View PDFchevron_right

Prospective validation of first-trimester combined screening for trisomy 21

Adolfo Etchegaray

Ultrasound in Obstetrics and Gynecology, 2009

View PDFchevron_right

Noninvasive Prenatal Detection of Trisomy 21 by an Epigenetic–Genetic Chromosome-Dosage Approach

Susan Crocker

Clinical Chemistry, 2009

View PDFchevron_right

Screening for fetal trisomy 21 in gestational weeks 6 and 7

Olav Petersen

Acta Obstetricia et Gynecologica Scandinavica, 2010

View PDFchevron_right

Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18

Mary Norton

American Journal of Obstetrics and Gynecology, 2012

View PDFchevron_right

Epigenetic-Genetic Chromosome Dosage Approach for Fetal Trisomy 21 Detection Using an Autosomal Genetic Reference Marker

Ranjit Akolekar

PLoS ONE, 2010

View PDFchevron_right

Genome-wide normalized score: a novel algorithm to detect fetal trisomy 21 during non-invasive prenatal testing

Ming Chen

ULTRASOUND OBSTET GYNECOL, 2014

View PDFchevron_right

Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies

Kevin Spencer

American Journal of Obstetrics and Gynecology, 2005

View PDFchevron_right

First-trimester screening for trisomy 21 with adjustment for biochemical results of previous pregnancies

Argyro Syngelaki

Fetal diagnosis and therapy, 2011

View PDFchevron_right

Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy

Kevin Williams

Annals of Clinical Biochemistry, 2002

View PDFchevron_right

Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18

Marion Wagner, Argyro Syngelaki

American journal of obstetrics and gynecology, 2012

View PDFchevron_right

One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies

Kevin Spencer

Ultrasound in Obstetrics and Gynecology, 2002

View PDFchevron_right

First-Trimester Screening for Trisomies 21, 18 and 13 by Ultrasound and Biochemical Testing

Argyro Syngelaki

Fetal Diagnosis and Therapy, 2014

View PDFchevron_right

First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing

Argyro Syngelaki

Fetal diagnosis and therapy, 2014

View PDFchevron_right

First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing

Argyro Syngelaki

Ultrasound in Obstetrics & Gynecology, 2013

View PDFchevron_right